This article has been updated with additional information from Biocartis.
NEW YORK (GenomeWeb) – Biocartis announced today that it has raised €80 million ($94.7 million) through a private placement via an accelerated bookbuild offering of 6.4 million new shares.
The firm said it sold the shares at an issue price of €12.50 each, and that the total 6.4 million shares represent approximately 14.3 percent of its outstanding shares.